If there's one thing investors have a love-hate relationship with, it's drama. Certain kinds of drama send a stock skyrocketing, while anything that triggers uncertainty sends it plummeting. Lifecore Biomedical Inc (NASDAQ:LFCR) has certainly seen its share of drama over the past year or so, and investors generally haven't been happy.
Shares of Lifecore Biomedical have tumbled 15% over the last year, although they're up about 2% year to date.
Long-running special situation
However, several hedge funds have stuck with the company throughout all the drama and uncertainties and now are starting to see light at the end of...
